Daniel Ross, MD
Foot and Ankle Surgery · Flowood, MSNPI 1841724408
Payments from drug & device makers
What this record shows
This record is dominated by grants: $10,000 of the $16,353 with a category attached, or 61.1%. Arthrex accounts for 76.1% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $10,992 and has fallen 79.3% since, to $2,270 in 2025.
Across 76 payments — averaging $215.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$12K
- ALON Medical Technology$1K
- Stryker$1K
- Zimmer Biomet$407
- Paragon 28, Inc.$346
- Ossio Inc$144
- plus $590 from 12 others
What the payments were for
- Grants$10,00061%
- Travel & lodging$3,54022%
- Food & beverage$2,81317%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 24 | $12,451 |
| ALON Medical Technology | 6 | $1,380 |
| Stryker | 13 | $1,035 |
| Zimmer Biomet | 9 | $407 |
| Paragon 28, Inc. | 3 | $346 |
| Ossio Inc | 1 | $144 |
| Johnson & Johnson(2 entities) | 2 | $112 |
| Vertex | 4 | $69 |
| Organogenesis Inc. | 2 | $68 |
| Peerless Surgical Inc. | 1 | $68 |
| Kerecis Limited | 2 | $66 |
| Innovation Technologies Inc | 2 | $52 |
| Smith+Nephew | 1 | $41 |
| Pacira Pharmaceuticals Incorporated | 2 | $31 |
| Ferring Pharmaceuticals Inc. | 1 | $28 |
| Bioventus LLC | 1 | $24 |
| Boston Scientific | 1 | $16 |
| Treace Medical Concepts, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY ADAPTIS$407
- Product Portfolio$266
- AUGMENT INJECTABLE$169
- Trabecular Metal (TM)$134
- INFINITY$107
- INBONE$107
- ROSA$103
How this compares
Too few foot and ankle surgery providers in Mississippito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 34 | $927 |
| Meloxicam | 167 | $464 |
| Ondansetron OdtOndansetron | 15 | $191 |
| Gabapentin | 43 | $149 |
| Ibuprofen | 11 | $88 |
| Oxycodone Hcl | 16 | $74 |
| Methylprednisolone | 15 | $69 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $61 |
| Tramadol Hcl | 20 | $59 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Flowood
- Marion LundOxford$46K
- John KoskoHattiesburg$40K
- Lori ReedJackson$28K
- Jeremy AdamsTupelo$17K
- Judith SmithBiloxi$8K
- Jeffery VanyperenAmory$6K
- Steven GeorgianLucedale$4K
- Ashley BlackwellJackson$2K
- Richard CukeljCleveland$2K
- Stanitia DavisJackson$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.